AS2863619 free base is primarily utilized in research and development within the pharmaceutical industry, particularly in the study of neurodegenerative diseases. Its application is focused on investigating potential therapeutic effects on conditions such as Alzheimer's disease, Parkinson's disease, and other forms of dementia. Researchers employ this compound to explore its interaction with specific biological targets, aiming to develop novel treatments that can modulate disease progression. Additionally, it is used in preclinical studies to assess its efficacy, safety, and pharmacokinetic properties, providing valuable insights for future drug development. The compound’s role in advancing understanding of neurological disorders makes it a significant tool in the quest for effective therapies.